title: Fixed ratio discrimination training increases in vivo striatal dopamine in neonatal 6-OHDA-lesioned rats.
abstract: Massed training in the conditional discrimination task, the fixed ratio discrimination (FRD) task led to elevated extracellular dopamine (DA) concentrations in the neonatal 6-hydroxydopamine (6-OHDA)-treated rat, a model of Lesch-Nyhan disease (LND). Rats neonatally treated with 6-OHDA or its vehicle were, as adults, implanted with microdialysis probes and assessed for basal pretraining concentrations of DA and its major metabolites. Subsequently, microdialysis samples were collected each day following three separate FRD training periods (trained group) or three separate periods of noncontingent food presentations (untrained group). The present study found that there were significant increases in extracellular DA in the caudate-putamen from basal pretraining concentrations in the repeated sample collections of trained 6-OHDA-lesioned animals but not in the samples of untrained 6-OHDA-lesioned animals. Consistent with previous studies [Brain Res. 508 (1990) 30.], there was an increase in the extracellular concentrations as compared to tissue concentrations of DA and 3,4-dihydroxyphenylacetic acid (DOPAC). Similar to our previous studies with long-term FRD training [Pharmacol. Biochem. Behav. 51 (1995) 861; Brain Res. 713 (1996) 246.], there was also an indication of an increase in cortical and striatal tissue concentration of DA in the trained 6-OHDA-lesioned animals as compared to the untrained 6-OHDA-lesioned animals. The elevations in striatal DA concentrations following operant performance in the present study illustrate how operant procedures of the behavior therapy used with individuals with LND and other mental retardation syndromes may interact with the modulation of dopaminergic function by the pharmaceutical application of DA antagonists to suppress aberrant behaviors.
authors.affiliation: Schiefelbusch Institute for Life Span Studies, 1052 Dole Human Development Center, University of Kansas, Lawrence, KS 66045, USA. psloupe@dole.lsi.ukans.edu
authors.forename: Pippa S
authors.initials: PS
authors.lastname: Loupe
authors.forename: Xiao
authors.initials: X
authors.lastname: Zhou
authors.forename: Malonne I
authors.initials: MI
authors.lastname: Davies
authors.forename: Stephen R
authors.initials: SR
authors.lastname: Schroeder
authors.forename: Richard E
authors.initials: RE
authors.lastname: Tessel
authors.forename: Susan M
authors.initials: SM
authors.lastname: Lunte
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D001923:Brain Chemistry; D002851:Chromatography, High Pressure Liquid; D004193:Discrimination Learning / Q000187:drug effects*; D004192:Discrimination, Psychological / Q000187:drug effects; D004298:Dopamine / Q000378:metabolism*; D005110:Extracellular Space / Q000187:drug effects / Q000378:metabolism; D005260:Female; D017551:Microdialysis; D017072:Neostriatum / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D016627:Oxidopamine; D011247:Pregnancy; D051381:Rats; D017207:Rats, Sprague-Dawley; D012055:Reinforcement Schedule; D013563:Sympathectomy, Chemical; D013565:Sympatholytics
chemical_list: D013565:Sympatholytics; D016627:Oxidopamine; D004298:Dopamine